Trump buys up entire stock of coronavirus drug remdesivir – sparking fury among medics

Published by : The Sun
The US has bought up virtually all stocks of a drug shown to work against Covid-19 - raising fears Brits won't be able to get hold of it until autumn.

The decision by the Trump administration has sparked fury with leading scientists who have raised concerns over "fair access" to remdesivir.

The anti-viral drug was originally developed for use against Ebola but trials showed that it helped patients hospitalised with coronavirus recover almost a third faster.

Health Secretary Matt Hancock hailed it the "biggest step forward" in treating Covid-19 when it was given approval for use on the NHS in May.

But now there are concerns patients in the UK won't get widespread access to the treatment after the US bought more than 500,000 doses.

It makes up the entire global supply for July and 90 per cent of stocks for August and September.

Read more
Trump buys up ENTIRE stock of coronavirus drug remdesivir – sparking fury among medics
https://www.thesun.co.uk/news/11996172/coronavirus-remdesivir-global-stock-bought-trump/

From Brexit breaking news to HD movie trailers, The Sun newspaper brings you the latest news videos and explainers from the UK and around the world.

Become a Sun Subscriber and hit the bell to be the first to know

Read The Sun: http://www.thesun.co.uk
Like The Sun on Facebook: https://www.facebook.com/thesun/
Follow The Sun on Twitter: https://twitter.com/TheSun
Subscribe to The Sun on Snapchat: https://www.snapchat.com/discover/The_Sun/1633225139
cached video

The Sun news breaking news donald trump intelligence briefed brief read bounty press iran iraq Trump buys up entire stock of coronavirus drug remdesivir remdesivir covid-19 drug covid relief drug coronavirus coronavirus task force mike pence The anti-viral drug virtually all stocks of a drug Donald Trump Fauci Brits won't be able to get hold of remdesivir British supply of remdesivir us hoard remdesivir gilead US buy up all remdesivir stock